+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain



Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain



Nuclear Medicine and Biology 31(5): 533-541



A radioiodinated ligand, (R)-N-methyl-(2-[(125)I]iodo-phenoxy)-3-phenylpropylamine, [(125)I]2-INXT, targeting norepinephrine transporters (NET), was successfully prepared. A no-carrier-added product, [(125)I]2-INXT, displayed a saturable binding with a high affinity (K(d)=0.06 nM) in the homogenates prepared from rat cortical tissues as well as from LLC-PK(1) cells expressing NET. A relatively low number of binding sties (B(max)=55 fmol/mg protein) measured with [(125)I]2-INXT in rat cortical homogenates is consistent with the value reported for a known NET ligand, [(3)H]nisoxetine. Competition studies with various compounds on [(125)I]2-INXT binding clearly confirmed the pharmacological specificity and selectivity for NET binding sites. Following a tail-vein injection of [(125)I]2-INXT in rats, a good initial brain uptake was observed (0.56% dose at 2 min) followed by a slow washout from the brain (0.2% remained at 3 hours post-injection). The hypothalamus (a NET-rich region) to striatum (a region devoid of NET) ratio was 1.5 at 3 hours post-i.v. injection. Pretreatment of rats with nisoxetine significantly inhibited the uptake of [(125)I]2-INXT (70-100% inhibition) in locus coeruleus, hypothalamus and raphe nuclei, regions known to have a high density of NET; whereas escitalopram, a serotonin transporter ligand, did not show a similar effect. Ex vivo autoradiography of rat brain sections of [(125)I]2-INXT (at 3 hours after an i.v. injection) displayed an excellent regional brain localization pattern corroborated to the specific NET distribution in the brain. The specific brain localization was significantly reduced by a dose of nisoxetine pretreatment. Taken together, the data suggest that [(123)I]2-INXT may be useful for mapping NET binding sites in the brain.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050272373

Download citation: RISBibTeXText

PMID: 15219270

DOI: 10.1016/j.nucmedbio.2004.03.001


Related references

Effects of local anaesthetic agents on nisoxetine binding to recombinant human norepinephrine transporters. British Journal of Pharmacology 128(PROC Suppl. ): 178P, 1999

Selective in vitro and in vivo binding of (125I)ADAM to serotonin transporters in rat brain. Synapse (New York) 38(4): 403-412, 2000

Characterization of desamino-5-(125I)Iodo-3-Methoxy-Zacopride ((125I)MIZAC) binding to 5-HT3 receptors in the rat brain. Progress in Neuro Psychopharmacology and Biological Psychiatry 22(2): 397-410, 1998

Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 22(2): 397-410, 1998

Binding of tritiated nisoxetine to rat brain a new radioligand for norepinephrine uptake sites. Society for Neuroscience Abstracts 16(1): 524, 1990

Paradoxical sleep deprivation decreases nisoxetine binding to the norepinephrine transporter in rat brain. Society for Neuroscience Abstracts 23(1-2): 1064, 1997

Norepinephrine transporters in rat placenta labeled with [3H]nisoxetine. Journal of Pharmacology and Experimental Therapeutics 284(2): 736-743, 1998

Rapid visualization of NMDA receptors in the brain: characterization of (+)-3-[125I]-iodo-MK-801 binding to thin sections of rat brain. Journal of Neuroscience Methods 46(1): 17-25, 1993

In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience 159(1): 271-282, 2009

2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. European Journal of Pharmacology 301(1-3): 159-168, 1996

Mapping dopamine transporters in the human brain with novel selective cocaine analog (125I)RTI-121. Synapse (New York) 21(4): 364-372, 1995

Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121. Synapse 21(4): 364-372, 1995

Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive. Journal of Neuroscience Methods 203(1): 19-27, 2012

In vivo binding and autoradiographic imaging of (+)-3-[125I]Iodo-MK-801 to the NMDA receptor-channel complex in rat brain. International Journal of Radiation Applications and Instrumentation. Part B Nuclear Medicine and Biology 19(3): 319-326, 1992

High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12(1): 27-36, 1992